Sort   by:  
 Page size 
UnknownRole of genetic polymorphisms in hepatitis C virus chronic infection.

Aim

To analyze the host genetics factors influencing the clinical course and the response to antiviral treatment in patients with chronic hepatitis C (CHC).

Methods

We conducted an electronic search on the PubMed and MEDLINE (2000-2014) databases and Cochrane library (2000-2014). A to...
S-EPMC4568530 | biostudies-literature
UnknownHepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals.
About 130-170 million people are infected with the hepatitis C virus (HCV) worldwide and more than 350000 people die each year of HCV-related liver diseases. The combination of pegylated interferon (Peg-IFN) and ribavirin (RBV) was recommended as the treatment of choice for chronic hepatitis C for n...
S-EPMC4600577 | biostudies-literature
UnknownTreatment of chronic hepatitis C in patients with HIV/HCV coinfection.
Hepatitis C virus (HCV) infection is one of the most frequent causes of comorbidity and mortality in the human immunodeficiency virus (HIV) population, and liver-related mortality is now the second highest cause of death in HIV-positive patients, so HCV infection should be countered with adequate an...
S-EPMC4308522 | biostudies-literature
Sort   by:  
 Page size